Search

everythinglearnresearchcommunity

for

Search:↓

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Ankle braces reduce motion, while external focus improves hip and knee movements.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Retinoids may help treat lupus nephritis and reduce steroid use.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A patient got Herpes zoster after a knee injection, possibly due to the injection's trauma, but more evidence is needed.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Majocchi’s granuloma should be considered when rashes don't improve with typical treatments.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.